Atlas Trials

Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer

Clinical trial NCT03617913 · COMPLETED

Trial details

NCT number
NCT03617913
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder Carcinoma Infiltrating the Muscle of the Bladder WallStage II Bladder Cancer AJCC v8Stage II Renal Pelvis Cancer AJCC v8Stage II Ureter Cancer AJCC v8Stage II Urethral Cancer AJCC v8Stage III Bladder Cancer AJCC v8Stage III Renal Pelvis Cancer AJCC v8Stage III Ureter Cancer AJCC v8Stage III Urethral Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8Stage IIIB Bladder Cancer AJCC v8Urethral Urothelial Carcinoma
Start date
2018-09-19
Primary completion
2019-11-14
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.